Clinical Trials in Pensacola, United States
Locations / Pensacola, United States
Delta Trials lists 53 clinical trials conducted in Pensacola, United States, making it a notable site of clinical research activity. These trials addressing 337 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Pensacola research landscape.
53
Total Trials
337
Conditions
1
Terminated since 2020
Browse by condition (337 total)
- All Recurrent langerhans cell histiocytosis trials
- Refractory malignant solid neoplasm 3 trialsAll Refractory malignant solid neoplasm trials
- Recurrent malignant solid neoplasm 3 trialsAll Recurrent malignant solid neoplasm trials
- Stage iiib lung cancer ajcc v8 3 trialsAll Stage iiib lung cancer ajcc v8 trials
- Recurrent soft tissue sarcoma 3 trialsAll Recurrent soft tissue sarcoma trials
- Recurrent osteosarcoma 3 trialsAll Recurrent osteosarcoma trials
- Focal epilepsy 3 trialsAll Focal epilepsy trials
- Recurrent rhabdomyosarcoma 3 trialsAll Recurrent rhabdomyosarcoma trials
- Recurrent hepatoblastoma 3 trialsAll Recurrent hepatoblastoma trials
- Refractory osteosarcoma 3 trialsAll Refractory osteosarcoma trials
- Low grade glioma 3 trialsAll Low grade glioma trials
- Refractory soft tissue sarcoma 3 trialsAll Refractory soft tissue sarcoma trials
- All Refractory langerhans cell histiocytosis trials
- Wilms tumor 3 trialsAll Wilms tumor trials
- B acute lymphoblastic leukemia 3 trialsAll B acute lymphoblastic leukemia trials
- Refractory non-hodgkin lymphoma 2 trialsAll Refractory non-hodgkin lymphoma trials
- Refractory medulloblastoma 2 trialsAll Refractory medulloblastoma trials
- Rhabdomyosarcoma 2 trialsAll Rhabdomyosarcoma trials
- Classic hodgkin lymphoma 2 trialsAll Classic hodgkin lymphoma trials
- Refractory malignant glioma 2 trialsAll Refractory malignant glioma trials